Assessment of skeletal muscle alterations and circulating myokines in metabolic dysfunction-associated steatotic liver disease: A cross-sectional study

[Background] Skeletal muscle alterations (SMAs) are being increasingly recognized in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and appear to be associated with deleterious outcomes in these patients. However, their actual prevalence and pathophysiology remain to...

Descripción completa

Detalles Bibliográficos
Autores: Real-Martínez, Yolanda, Fernández-García, Carlos Ernesto, Fuertes, Esther, Calvo Soto, Mario, Berlana, Ángela, Barrios, Vicente, Caldas, Maria, González Moreno, Leticia, García-Buey, Luisa, Molina Baena, Begoña, Sampedro-Nuñez, Miguel, Beceiro, Maria J., García-Monzón, Carmelo, González-Rodríguez, Águeda
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/413713
Acceso en línea:http://hdl.handle.net/10261/413713
Access Level:acceso abierto
Palabra clave:Skeletal muscle alterations
Myokines
Metabolic dysfunction-associated steatotic liver disease
Liver fibrosis
Hepatosteatosis
Descripción
Sumario:[Background] Skeletal muscle alterations (SMAs) are being increasingly recognized in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and appear to be associated with deleterious outcomes in these patients. However, their actual prevalence and pathophysiology remain to be elucidated.

Similares en LA Referencia